Conditions: Allergic Rhinitis
Keywords: allergic rhinitis pediatric subjects BDP nasal aerosol
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 547
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of Beclomethasone dipropionate (BDP) nasal aerosol in subjects with Perennial Allergic Rhinitis (PAR).

Detailed description:

Arms:
arm 1: BDP nasal aerosol: 80 mcg dose once daily in the morning. Participants/parents administer 40 mcg BDP (one spray per nostril) during the 12-week Treatment Period. arm 2: Placebo nasal aerosol: Participants/parents administer placebo (no medication) (one spray per nostril) once daily in the morning during the 12-week Treatment Period.

Interventions: intervention 1: BDP Nasal Aerosol intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: